Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Pfeilschifter

Showing results (111-120 of 320) with videos related to

Pageof 32
Sort By:
The Journal of Investigative Dermatology|November 20, 2009
Epithelial overexpression of SOCS-3 in transgenic mice exacerbates wound inflammation in the presence of elevated TGF-beta1Andreas Linke, Itamar Goren, Michael R Bösl, et al.
The Journal of Investigative Dermatology|November 20, 2009
The suppressor of cytokine signaling (SOCS)-3 determines keratinocyte proliferative and migratory potential during skin repairAndreas Linke, Itamar Goren, Michael R Bösl, et al.
Molecular Cancer Therapeutics|February 20, 2007
Interleukin-18 directly activates T-bet expression and function via p38 mitogen-activated protein kinase and nuclear factor-kappaB in acute myeloid leukemia-derived predendritic KG-1 cellsMalte Bachmann, Cristina Dragoi, Marco A Poleganov, et al.
Biochemical Pharmacology|June 21, 2005
Dissociated glucocorticoids equipotently inhibit cytokine- and cAMP-induced matrix degrading proteases in rat mesangial cellsWolfgang Eberhardt, Tobias Kilz, El-Sayed Akool, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophagesStefan El-Gayar, Heike Thüring-Nahler, Josef Pfeilschifter, et al.
The American Journal of Pathology|February 5, 2013
Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injuryPatrick Scheiermann, Malte Bachmann, Itamar Goren, et al.
Frontiers in Pharmacology|January 22, 2016
Though Active on RINm5F Insulinoma Cells and Cultured Pancreatic Islets, Recombinant IL-22 Fails to Modulate Cytotoxicity and Disease in a Protocol of Streptozotocin-Induced Experimental DiabetesAnika Berner, Malte Bachmann, Christine Bender, et al.
The American Journal of Pathology|February 28, 2009
Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen RAnke Doller, Stefan Gauer, Ewelina Sobkowiak, et al.
Investigative Ophthalmology & Visual Science|July 31, 2002
Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cellsWolfgang Schacke, Karl-Friedrich Beck, Josef Pfeilschifter, et al.
British Journal of Pharmacology|March 28, 2013
IL-22 in tissue-protective therapyHeiko Mühl, Patrick Scheiermann, Malte Bachmann, et al.
Pageof 32

Showing results (111-120 of 320) with videos related to

Sort By:
Pageof 32
The Journal of Investigative Dermatology|November 20, 2009
Epithelial overexpression of SOCS-3 in transgenic mice exacerbates wound inflammation in the presence of elevated TGF-beta1Andreas Linke, Itamar Goren, Michael R Bösl, et al.
The Journal of Investigative Dermatology|November 20, 2009
The suppressor of cytokine signaling (SOCS)-3 determines keratinocyte proliferative and migratory potential during skin repairAndreas Linke, Itamar Goren, Michael R Bösl, et al.
Molecular Cancer Therapeutics|February 20, 2007
Interleukin-18 directly activates T-bet expression and function via p38 mitogen-activated protein kinase and nuclear factor-kappaB in acute myeloid leukemia-derived predendritic KG-1 cellsMalte Bachmann, Cristina Dragoi, Marco A Poleganov, et al.
Biochemical Pharmacology|June 21, 2005
Dissociated glucocorticoids equipotently inhibit cytokine- and cAMP-induced matrix degrading proteases in rat mesangial cellsWolfgang Eberhardt, Tobias Kilz, El-Sayed Akool, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophagesStefan El-Gayar, Heike Thüring-Nahler, Josef Pfeilschifter, et al.
The American Journal of Pathology|February 5, 2013
Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injuryPatrick Scheiermann, Malte Bachmann, Itamar Goren, et al.
Frontiers in Pharmacology|January 22, 2016
Though Active on RINm5F Insulinoma Cells and Cultured Pancreatic Islets, Recombinant IL-22 Fails to Modulate Cytotoxicity and Disease in a Protocol of Streptozotocin-Induced Experimental DiabetesAnika Berner, Malte Bachmann, Christine Bender, et al.
The American Journal of Pathology|February 28, 2009
Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen RAnke Doller, Stefan Gauer, Ewelina Sobkowiak, et al.
Investigative Ophthalmology & Visual Science|July 31, 2002
Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cellsWolfgang Schacke, Karl-Friedrich Beck, Josef Pfeilschifter, et al.
British Journal of Pharmacology|March 28, 2013
IL-22 in tissue-protective therapyHeiko Mühl, Patrick Scheiermann, Malte Bachmann, et al.
Pageof 32